The WHO Stop-TB Strategy has dramatically improved the control of TB worldwide. The emergence and the spread of anti-TB drug resistance can be prevented by the prescription of an effective anti-TB therapy. Drug sensitivity testing results are helpful to identify the most effective anti-TB drugs. WHO recommends to treat new TB cases for 6 months (H, R, Z, and E for 2 months, and H and R for other 4 months). WHO recommends to prescribe ART in all TB/HIV coinfected individuals (within the first 2 months after the start of the anti-TB therapy). Clinical management of adverse events due to anti-TB drugs increases the probability of treatment success.
ASJC Scopus subject areas